Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clopidogrel
100%
Functional Testing
100%
Testing Method
100%
Antiplatelet Activity
100%
P2Y12 Receptor Antagonist
100%
Platelet Function Tests
40%
Clinical Trials
20%
Coronary Artery Disease
20%
Patients with Coronary Artery Disease
20%
Aspirin
20%
Acute Coronary Syndrome
20%
Dual Antiplatelet Therapy
20%
Antiplatelet Therapy
20%
Clinical Efficacy
20%
Poor Clinical Outcomes
20%
Coronary Stent Implantation
20%
Routine Clinical Practice
20%
Downstream Effects
20%
Personalized Medicine
20%
P2Y12 Receptor
20%
Pharmacodynamic Interactions
20%
Patient-centered Approach
20%
Effect-based Methods
20%
P2Y12 Antagonists
20%
Recurrent Cardiovascular Events
20%
Medicine and Dentistry
Antiplatelet
100%
Clopidogrel
100%
Receptor Antagonist
100%
Purinergic P2Y12 Receptor
100%
Coronary Artery Disease
40%
Thrombocyte Function
40%
Clinical Trial
20%
Cardiovascular System
20%
Acute Coronary Syndrome
20%
Acetylsalicylic Acid
20%
Pharmacodynamics
20%
Personalized Medicine
20%
Function Test
20%
Pharmacology, Toxicology and Pharmaceutical Science
Clopidogrel
100%
Antiplatelet
100%
Receptor Antagonist
100%
Purinergic P2Y12 Receptor
100%
Coronary Artery Disease
40%
Clinical Trial
20%
Pharmacodynamics
20%
Acetylsalicylic Acid
20%
Acute Coronary Syndrome
20%
Nursing and Health Professions
Clopidogrel
100%
Purinergic P2Y12 Receptor
100%
Coronary Artery Disease
40%
Pharmacodynamics
20%
Personalized Medicine
20%
Clinical Outcome
20%
Clinical Practice
20%
Coronary Stent
20%
Dual Antiplatelet Therapy
20%
Acute Coronary Syndrome
20%
Clinical Effectiveness
20%
Blood Clotting Parameters
20%
Biochemistry, Genetics and Molecular Biology
Clopidogrel
100%
Receptor Antagonist
100%
P2Y12
100%
Thrombocyte Function
40%
Coronary Artery Disease
40%
Clinical Trial
20%
Pharmacodynamics
20%
Neuroscience
Receptor Antagonist
100%
Clopidogrel
100%
Purinergic P2Y12 Receptor
100%
Platelet
40%
Aspirin
20%
Acute Coronary Syndrome
20%
P2Y12
20%